Allworth Financial LP raised its holdings in shares of Cigna Group (NYSE:CI – Free Report) by 11.1% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 31,897 shares of the health services provider’s stock after acquiring an additional 3,176 shares during the quarter. Allworth Financial LP’s holdings in Cigna Group were worth $9,194,000 at the end of the most recent reporting period.
A number of other institutional investors have also made changes to their positions in CI. Harbor Capital Advisors Inc. lifted its position in Cigna Group by 119.5% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after buying an additional 49 shares in the last quarter. Collier Financial bought a new stake in Cigna Group during the third quarter worth about $34,000. Traub Capital Management LLC acquired a new position in Cigna Group during the second quarter valued at approximately $48,000. Founders Capital Management boosted its position in Cigna Group by 53.0% during the third quarter. Founders Capital Management now owns 153 shares of the health services provider’s stock valued at $44,000 after purchasing an additional 53 shares during the last quarter. Finally, Twin Peaks Wealth Advisors LLC bought a new position in Cigna Group in the second quarter valued at approximately $52,000. Institutional investors own 86.99% of the company’s stock.
Analyst Ratings Changes
CI has been the topic of several recent analyst reports. Robert W. Baird lowered their price target on Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research report on Thursday, December 11th. Royal Bank Of Canada decreased their target price on shares of Cigna Group from $344.00 to $333.00 and set an “outperform” rating for the company in a research note on Friday, February 6th. Truist Financial boosted their target price on shares of Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a report on Tuesday, February 17th. UBS Group reaffirmed a “buy” rating and set a $375.00 price target on shares of Cigna Group in a research report on Monday, February 9th. Finally, Mizuho set a $325.00 price target on shares of Cigna Group in a research note on Friday, January 9th. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $333.11.
Cigna Group Trading Up 0.0%
CI stock opened at $264.72 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. The company’s 50-day simple moving average is $278.19 and its 200 day simple moving average is $281.97. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The company has a market capitalization of $69.76 billion, a PE ratio of 11.94, a price-to-earnings-growth ratio of 0.92 and a beta of 0.27.
Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping the consensus estimate of $7.88 by $0.20. The business had revenue of $72.50 billion during the quarter, compared to analysts’ expectations of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business’s revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, sell-side analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.
Cigna Group Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Thursday, March 5th were given a dividend of $1.56 per share. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend was Thursday, March 5th. Cigna Group’s dividend payout ratio (DPR) is currently 28.13%.
Insider Buying and Selling
In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the transaction, the insider owned 32,647 shares in the company, valued at $9,432,044.77. This trade represents a 6.60% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares of the company’s stock, valued at $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.70% of the company’s stock.
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
See Also
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
